Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center.

Jung, Seung-Won; Lim, Sung Ha; Jeon, Jae Joon; Heo, Yeon-Woo; Choi, Mi Soo; Hong, Seung-Phil

Jung, Seung-Won; Lim, Sung Ha; Jeon, Jae Joon; Heo, Yeon-Woo; Choi, Mi Soo; Hong, Seung-Phil.

Afiliación

Jung SW; Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.
Lim SH; Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.
Jeon JJ; Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.
Heo YW; Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.
Choi MS; Department of Dermatology, Dankook University College of Medicine, Cheonan 31116, Korea.
Hong SP; Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju 26426, Korea.

Biomedicines ; 10(5)2022 May 03.

Article en En | MEDLINE | ID: mdl-35625795

Palabras clave

direct comparison in real world; guselkumab; psoriasis; secukinumab; ustekinumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 3_ND Problema de salud: 1_geracao_evidencia_conhecimento / 3_tuberculosis Tipo de estudio: Prognostic_studies Idioma: En Revista: Biomedicines Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google